Hanabusa Women’s Clinic, Kobe, Hyogo, Japan
Research Article
Effect of Different Durations of Shawkea DE-T1 Administration on Blastocyst Obtained Rate in Women Receiving IVF-ET Treatment: A Secondary Analysis of a Cohort Study
Author(s): Hui SHAO*, Munehiro NAKAMOTO, Yoji YAMAGUCHI, Toshiaki NOZAKI, Xi DONG, Dongzi YANG, Shuang JIAO, Weifen DENG, Shoji KOKEGUCHI and Masahide SHIOTANI
Objective: To explore the appropriate duration of Shawkea DE-T1 use, and to provide a basis for the optimization
of the Shawkea DE-T1 administration duration for different women.
Methods: Based on a previous retrospective cohort study, 1,014 patients aged ≥ 30 years who used In vitro Fertilization
(IVF) for conception at Hanabusa Women’s Clinic, Kobe, Japan, were included in this secondary analysis and were
allocated to an Shawkea DE-T1-administration group (n=712) and a control group (n=302) based on their use of
Shawkea DE-T1. All patients in the two groups received interventions following the guidelines of the Japanese
Institution for Standardizing Assisted Reproductive Technology Intervention, and patients in the administration
group were provided Shawkea DE-T1 as recommended by the Nutritional Supplemen.. View more»